Mary Ellen Csuka, MD, FACP

Publications

• Daniel J McCarty, MD: A Giant of Rheumatology.

  (Rosenthal AK, Csuka ME, Halverson P.) Rheum Dis Clin North Am. 2024 Feb;50(1):15-23 PMID: 37973282 SCOPUS ID: 2-s2.0-85169505673 11/17/2023

• Clinical and Molecular Findings After Autologous Stem Cell Transplantation or Cyclophosphamide for Scleroderma: Handling Missing Longitudinal Data.

  (Keyes-Elstein L, Pinckney A, Goldmuntz E, Welch B, Franks JM, Martyanov V, Wood TA, Crofford L, Mayes M, McSweeney P, Nash R, Georges G, Csuka ME, Simms R, Furst D, Khanna D, Clair EWS, Whitfield ML, Sullivan KM.) Arthritis Care Res (Hoboken). 2023 Feb;75(2):307-316 PMID: 34533286 PMCID: PMC8926930 09/18/2021

• Lymphocyte subset abnormalities in early severe scleroderma favor a Th2 phenotype and are not altered by prior immunosuppressive therapy.

  (Shah A, Storek J, Woolson R, Pinckney A, Keyes-Elstein L, Wallace PK, Sempowski GD, McSweeney P, Mayes MD, Crofford L, Csuka ME, Phillips K, Khanna D, Simms R, Ballen K, LeClercq S, Clair WS, Nixon AB, Nash R, Wener M, Brasington R, Silver R, Griffith LM, Furst DE, Goldmuntz E, Sullivan KM.) Rheumatology (Oxford). 2022 Oct 06;61(10):4155-4162 PMID: 35108379 PMCID: PMC9536786 02/03/2022

• Determinants of low bone mineral density in people with multiple sclerosis: Role of physical activity.

  (Cleland BT, Papanek P, Ingraham BA, Harkins A, Garnier-Villarreal M, Woo D, Csuka ME, V Ng A.) Mult Scler Relat Disord. 2020 Feb;38:101864 PMID: 31801106 12/05/2019

• Efficacy of Osteoporosis Prevention Smartphone App.

  (Ryan P, Brown RL, Csuka ME, Papanek P.) Nurs Res. 2020;69(1):31-41 PMID: 31568199 PMCID: PMC7105101 10/01/2019

• Risk Factors for Mortality and Cardiopulmonary Hospitalization in Systemic Sclerosis Patients At Risk for Pulmonary Hypertension, in the PHAROS Registry.

  (Hsu VM, Chung L, Hummers LK, Shah A, Simms R, Bolster M, Hant FN, Silver RM, Fischer A, Hinchcliff ME, Varga J, Goldberg AZ, Derk CT, Schiopu E, Khanna D, Shapiro LS, Domsic RT, Medsger T, Mayes MD, Furst D, Csuka ME, Molitor JA, Saketkoo LA, Salazar CR, Steen VD.) J Rheumatol. 2019 Feb;46(2):176-183 PMID: 30275260 10/03/2018

• Background and method of the Striving to be Strong study a RCT testing the efficacy of a m-health self-management intervention.

  (Ryan P, Papanek P, Csuka ME, Brown ME, Hopkins S, Lynch S, Scheer V, Schlidt A, Yan K, Simpson P, Hoffman R, Striving to be Strong Team.) Contemp Clin Trials. 2018 Aug;71:80-87 PMID: 29894865 SCOPUS ID: 2-s2.0-85048278984 06/13/2018

• Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma.

  (Sullivan KM, Goldmuntz EA, Keyes-Elstein L, McSweeney PA, Pinckney A, Welch B, Mayes MD, Nash RA, Crofford LJ, Eggleston B, Castina S, Griffith LM, Goldstein JS, Wallace D, Craciunescu O, Khanna D, Folz RJ, Goldin J, St Clair EW, Seibold JR, Phillips K, Mineishi S, Simms RW, Ballen K, Wener MH, Georges GE, Heimfeld S, Hosing C, Forman S, Kafaja S, Silver RM, Griffing L, Storek J, LeClercq S, Brasington R, Csuka ME, Bredeson C, Keever-Taylor C, Domsic RT, Kahaleh MB, Medsger T, Furst DE, SCOT Study Investigators.) N Engl J Med. 2018 Jan 04;378(1):35-47 PMID: 29298160 PMCID: PMC5846574 01/04/2018

• Utility of B-type natriuretic peptides in the assessment of patients with systemic sclerosis-associated pulmonary hypertension in the PHAROS registry.

  (Chung L, Fairchild RM, Furst DE, Li S, Alkassab F, Bolster MB, Csuka ME, Derk CT, Domsic RT, Fischer A, Frech TM, Gomberg-Maitland M, Gordon JK, Hinchcliff M, Hsu V, Hummers LK, Khanna D, Medsger TAJ, Molitor JA, Preston IR, Schiopu E, Shapiro L, Hant F, Silver R, Simms R, Varga J, Steen VD, Zamanian RT.) Clin Exp Rheumatol. 2017;35 Suppl 106(4):106-113 PMID: 27908301 12/03/2016

• The Recurrence of Digital Ulcers in Patients with Systemic Sclerosis after Discontinuation of Oral Treprostinil.

  (Shah AA, Schiopu E, Chatterjee S, Csuka ME, Frech T, Goldberg A, Spiera R, Peng SL, McBride RJ, Cleveland JM, Steen V.) J Rheumatol. 2016 Sep;43(9):1665-71 PMID: 27307535 06/17/2016

• Development of pulmonary hypertension in a high-risk population with systemic sclerosis in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) cohort study.

  (Hsu VM, Chung L, Hummers LK, Wigley F, Simms R, Bolster M, Silver R, Fischer A, Hinchcliff ME, Varga J, Goldberg AZ, Derk CT, Schiopu E, Khanna D, Shapiro LS, Domsic RT, Medsger T, Mayes MD, Furst D, Csuka ME, Molitor JA, Alkassab F, Steen VD.) Semin Arthritis Rheum. 2014 Aug;44(1):55-62 PMID: 24709277 04/09/2014

• Pulmonary hypertension and interstitial lung disease within PHAROS: impact of extent of fibrosis and pulmonary physiology on cardiac haemodynamic parameters.

  (Fischer A, Swigris JJ, Bolster MB, Chung L, Csuka ME, Domsic R, Frech T, Hinchcliff M, Hsu V, Hummers LK, Gomberg-Maitland M, Mathai SC, Simms R, Steen VD.) Clin Exp Rheumatol. 2014;32(6 Suppl 86):S-109-14 PMID: 25372796 11/06/2014